This report was prepared by Fatima Riaz (AVAC), with contributions from Kevin Fisher (AVAC), Jennifer Maple (IAVI), UNAIDS staff, and Mitchell Warren (AVAC) of the Resource Tracking for HIV Research and Development Working Group (herein referred to as “the Working Group”), with contributions from Jeanne Barron and Deirdre Grant.
Financial support for this project was provided by AVAC. In past years, support was also provided by the International AIDS Vaccine Initiative (IAVI), the Joint United Nations Programme on HIV/AIDS (UNAIDS), the International Partnership for Microbicides (IPM) and the Alliance for Microbicide Development (AMD).
This analysis is made possible by the generous support of several donors, including the Bill and Melinda Gates Foundation, and the American people through the US President’s Emergency Plan for AIDS Relief (PEPFAR) and the US Agency for International Development (USAID) as part of the Coalition to Accelerate and Support Prevention Research (CASPR) project. The contents are the responsibility of AVAC and do not necessarily reflect the views of PEPFAR, USAID or the United States Government. AVAC does not accept funding from the pharmaceutical industry.